title: Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases?
authors: Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Fl., USA; Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT, USA; Department of Addiction Research & Therapy, Malibu Beach Recovery Center, Malibu Beach, CA, USA; Dominion Diagnostics, LLC, North Kingstown, RI, USA; Institute of Integrative Omics and Applied Biotechnology, Nonakuri, Purba Medinipur, West Bengal, India; IGENE, LLC, Austin, Texas, USA; Department of Nutrigenomics, RDSolutions, LLC, La Jolla, CA, USA.
authors: Kenneth
authors: K
authors: Blum
authors: Departments of Psychiatry, Neurology, and Anatomy & Neurobiology, Boston University School of Medicine, and Boston VA Healthcare System, Boston, MA, 02118, USA.
authors: Marlene
authors: M
authors: Oscar-Berman
authors: Center for Psychiatric Medicine, North Andover, Massachusetts, USA.
authors: Seth H
authors: SH
authors: Blum
authors: IGENE, LLC, Austin, Texas, USA.
authors: Margaret A
authors: MA
authors: Madigan
authors: IGENE, LLC, Austin, Texas, USA.
authors: Roger L
authors: RL
authors: Waite
authors: Center for Psychiatric Medicine, North Andover, Massachusetts, USA.
authors: Thomas
authors: T
authors: McLaughlin
authors: Institute of Integrative Omics and Applied Biotechnology, Nonakuri, Purba Medinipur, West Bengal, India.
authors: Debmalya
authors: D
authors: Barh